New combination respiratory vaccine helps producers upgrade
protection against bovine respiratory disease in cattle
FLORHAM PARK, N.J., August 5, 2013 — Zoetis Inc., formerly the animal health business unit of Pfizer Inc., announces the licensure of BOVI-SHIELD GOLD ONE SHOT™. With BOVI-SHIELD GOLD ONE SHOT, producers get upgraded protection for their cattle against major respiratory viruses and Mannheimia (Pasteurella) haemolytica in one convenient dose.
BOVI-SHIELD GOLD ONE SHOT offers the longest demonstrated protection of the combination respiratory vaccines on the market. It helps protect cattle for at least 279 days against infectious bovine rhinotracheitis (IBR) virus and bovine viral diarrhea (BVD) Types 1 and 2 viruses — at least 30% longer than Vista® Once SQ and longer demonstrated protection than Pyramid® 5 + Presponse® SQ vaccine, which has no duration of immunity label claims.
The extended protection of BOVI-SHIELD GOLD ONE SHOT helps producers protect their cattle against IBR virus and BVD Types 1 and 2 viruses that cause bovine respiratory disease (BRD), which can result in losses as high as $240 per head.1,2
“BRD is a major health concern for cattle producers, and it’s the leading cause of economic losses,” said Jon Seeger, DVM, managing veterinarian with Zoetis Cattle and Equine Technical Services. “Having at least 279 days of respiratory immunity against IBR virus and BVD Types 1 and 2 viruses with BOVI-SHIELD GOLD ONE SHOT is especially advantageous because cattle are protected through the stresses that can result in BRD outbreaks — leaving the herd at weaning, processing, shipping, commingling and arrival at another operation.”
BOVI-SHIELD GOLD ONE SHOT helps protect cattle from respiratory disease caused by IBR virus; BVD Types 1 and 2 viruses; bovine respiratory syncytial virus (BRSV); parainfluenza 3 (PI3) virus; and M. haemolytica. It is the only combination respiratory vaccine that is labeled to prevent IBR, prevent BVD viremia and aid in the prevention of M. haemolytica, the No. 1 calf killer.3,4
“BOVI-SHIELD GOLD ONE SHOT incorporates components from two trusted products in one convenient dose, so animals receive superior protection from the major BRD-causing viruses and unmatched M. haemolytica protection,” Dr. Seeger explained. “Healthy calves have the best opportunity to gain weight quickly and efficiently.”
BOVI-SHIELD GOLD ONE SHOT is available in 5-, 10- or 50-dose vials and can be purchased through veterinarians or animal health retailers.
Zoetis (zō-EH-tis) is the leading animal health company, dedicated to supporting its customers and their businesses. Building on a 60-year history as the animal health business of Pfizer, Zoetis discovers, develops, manufactures and markets veterinary vaccines and medicines, with a focus on both farm and companion animals. In 2012, the company generated annual revenues of $4.3 billion. With approximately 9,300 employees worldwide at the beginning of 2013, Zoetis has a local presence in approximately 70 countries, including 29 manufacturing facilities in 11 countries. Its products serve veterinarians, livestock producers and people who raise and care for farm and companion animals in 120 countries. For more information on the company, visit www.zoetis.com.
Zoetis is the proud sponsor with the Smithsonian Institution Traveling Exhibitions and the American Veterinary Medical Association of the mobile educational exhibit Animal Connections: Our Journey Together. Families visiting the exhibit will explore the vast bonds between people and animals and learn about the important role veterinarians play in protecting animal and human health.
For further information, Contact:
Bader Rutter & Associates
Click here to download a photo of BOVI-SHIELD GOLD ONE SHOT™. Suggested photo caption: BOVI-SHIELD GOLD ONE SHOT™ from Zoetis is a new combination vaccine that offers upgraded viral and Mannheimia (Pasteurella) haemolytica respiratory protection for cattle in one convenient dose.
1 Hicks B. Impact of Morbidity on Performance and Profitability of Feedlot Cattle. Beef Cattle Research Update. Oklahoma State University. Panhandle Research and Extension Center. May 2006:1-2.
2 Grubbs ST, Kania SA, Potgieter LND. Prevalence of ovine and bovine respiratory syncytial virus infection in cattle determined with a synthetic peptide-based immunoassay. J Vet Diagn Invest 2001;13(2):128-132.
3 Powell J. Livestock Health Series: Bovine Respiratory Disease. University of Arkansas Cooperative Extension Service. FSA 3082, 2009.
4 Animal and Plant Health Inspection Service. Mortality of calves and cattle on U.S. beef cow-calf operations. U.S. Department of Agriculture. May 2010. Available at: http://www.aphis.usda.gov/animal_health/nahms/beefcowcalf/downloads/beef0708/Beef0708_is_Mortality.pdf. Accessed June 28, 2013.